Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sapna P Patel

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 15, 2018
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal MelanomaRené J Tavera, Marie-Andrée Forget, Young Uk Kim, et al.
Annals of Surgical Oncology|April 24, 2026
Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
Annals of Surgical Oncology|March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Nature Medicine|May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practiceClaus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Therapeutic Advances in Medical Oncology|June 19, 2025
Proceedings of the seventh annual Women in Melanoma ConferenceYana G Najjar, Marlana Orloff, Tara C Mitchell, et al.
Oncotarget|September 3, 2015
BRAF mutation testing with a rapid, fully integrated molecular diagnostics systemFilip Janku, Bart Claes, Helen J Huang, et al.
Oncoimmunology|July 7, 2017
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot studyYong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
Frontiers in Oncology|November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanomaJoel Ho, Jane Mattei, Michael Tetzlaff, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 15, 2018
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal MelanomaRené J Tavera, Marie-Andrée Forget, Young Uk Kim, et al.
Annals of Surgical Oncology|April 24, 2026
Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
Annals of Surgical Oncology|March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Nature Medicine|May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practiceClaus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Therapeutic Advances in Medical Oncology|June 19, 2025
Proceedings of the seventh annual Women in Melanoma ConferenceYana G Najjar, Marlana Orloff, Tara C Mitchell, et al.
Oncotarget|September 3, 2015
BRAF mutation testing with a rapid, fully integrated molecular diagnostics systemFilip Janku, Bart Claes, Helen J Huang, et al.
Oncoimmunology|July 7, 2017
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot studyYong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
Frontiers in Oncology|November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanomaJoel Ho, Jane Mattei, Michael Tetzlaff, et al.
Pageof 13